Literature DB >> 2580897

In vitro regulation of the pathogenic autoantibody response of New Zealand black mice. I. Loss with age of suppressive activity in T cell populations.

J S Moore, C E Calkins.   

Abstract

An investigation of the regulation of specific anti-self responses was initiated with the development of an in vitro system in which spleen cells from NZB mice were stimulated by syngeneic mouse erythrocytes (MRBC) to produce MRBC-specific autoantibody-secreting cells. The response was measured by a modification of the focus-forming cell (FFC) assay, which enumerates cells secreting IgG, which specifically bind MRBC. Spleen cells from 9- to 12-mo-old NZB mice developed MRBC-specific FFC after 3 to 5 days in culture with MRBC. Few FFC were detected in the absence of MRBC in culture. Spleen cells from young (1- to 4-mo-old) NZB mice developed few if any FFC. Spleen cell populations containing T cells from young NZB mice suppressed this anti-MRBC response, whereas B cell populations from these young mice did not. In contrast, spleen cells, including T cell-enriched populations from old, Coombs'-positive mice were not capable under the same conditions of producing equivalent suppression of this in vitro autoimmune response. These data suggest that a population of suppressor T cells that may control the autoimmune anti-MRBC response in young NZB mice is lost, or else its activity is masked in old NZB mice that are actively producing anti-MRBC antibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580897

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  CD8(+) T cells in human autoimmune arthritis: the unusual suspects.

Authors:  Alessandra Petrelli; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2016-06-03       Impact factor: 20.543

2.  Active role of T cells in promoting an in vitro autoantibody response to self erythrocytes in NZB mice.

Authors:  R D Miller; C E Calkins
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

Review 3.  Regulatory T cells essential to prevent the loss of self-tolerance in murine models of erythrocyte-specific autoantibody responses.

Authors:  Catherine E Calkins
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

4.  FCE20696, a new synthetic immunomodulator: immunopharmacological profile.

Authors:  A M Isetta; M C Fornasiero; M Ferrari; D Trizio
Journal:  Agents Actions       Date:  1989-11

5.  Long-term treatment of NZB mice with anti-CD4 results in wasting disease, lymphoid atrophy and chronic diarrhea.

Authors:  Geraldo Gs Oliveira; John Holton; Peter M Lydyard
Journal:  Gut Microbes       Date:  2010-05-24

6.  Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies.

Authors:  G G Oliveira; P R Hutchings; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Characterization of the spontaneous autoimmune (anti-erythrocyte) response in NZB mice using a pathogenic monoclonal autoantibody and its anti-idiotype.

Authors:  M J Caulfield; D Stanko; C Calkins
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

8.  Antigen specific, suppressor cells induced by the immunomodulator FCE 20696 in aged NZB/WF1 mice.

Authors:  M C Fornasiero; A M Isetta; M Ferrari; D Trizio
Journal:  Agents Actions       Date:  1986-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.